Bonesupport Holding AB (BONEX)

Stockholm
Currency in SEK
269.00
-0.80(-0.30%)
Closed·
BONEX Scorecard
Full Analysis
Impressive gross profit margins
BONEX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
266.40272.00
52 wk Range
244.00405.80
Key Statistics
Edit
Prev. Close
269.8
Open
268
Day's Range
266.4-272
52 wk Range
244-405.8
Volume
395.22K
Average Volume (3m)
201.13K
1-Year Change
7.6%
Book Value / Share
11.25
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BONEX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
426.00
Upside
+58.36%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

Bonesupport Holding AB News & Analysis

Show more

Bonesupport Holding AB Company Profile

Bonesupport Holding AB (publ), an orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; CERAMENT V, an injectable ceramic bone graft substitute that remodels to host bone and elutes Vancomycin during the critical first 30 days of bone healing, as well as treats and prevents bone infection. It also offers CERAMENT Bead Tray, an adjunctive local delivery option for surgeons for targeted delivery to osseous defects and for dead space management. In addition, the company develops preclinical product candidates to promote bone regrowth focusing on trauma, revision arthroplasty, chronic osteomyelitis, and foot and ankle surgery. Bonesupport Holding AB (publ) was founded in 1999 and is headquartered in Lund, Sweden.

Employees
140
Market
Sweden

Bonesupport Holding AB Earnings Call Summary for Q1/2025

  • Net sales surged 54% YoY to SEK 283.5M, with Cerament G sales up 92%, despite a 0.5% stock price dip post-earnings
  • Gross margin stable at 95% despite currency impacts; operating profit affected by SEK 30.4M due to currency fluctuations
  • U.S. market expansion continues with increased sales efforts; company exploring entry into spinal fusion market
  • Sales growth guidance set above 40% for the year, supported by 42% five-year revenue CAGR and favorable U.S. reimbursement changes
  • SOLARIO study publication anticipated; InvestingPro suggests stock slightly overvalued, but analysts see up to 35% upside potential
Last Updated: 2025/04/24, 11:30
Read Full Transcript

Compare BONEX to Peers and Sector

Metrics to compare
BONEX
Peers
Sector
Relationship
P/E Ratio
144.8x−8.4x−0.5x
PEG Ratio
−2.66−0.170.00
Price/Book
23.9x5.8x2.6x
Price / LTM Sales
17.8x37.0x3.0x
Upside (Analyst Target)
54.3%25.7%52.6%
Fair Value Upside
Unlock−5.4%8.8%Unlock

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 426.00
(+58.36% Upside)

Earnings

Latest Release
Apr 24, 2025
EPS / Forecast
0.18 / --
Revenue / Forecast
284.00M / 291.65M
EPS Revisions
Last 90 days

BONEX Income Statement

FAQ

What Is the Bonesupport (BONEX) Stock Price Today?

The Bonesupport stock price today is 269.00

What Stock Exchange Does Bonesupport Trade On?

Bonesupport is listed and trades on the Stockholm Stock Exchange stock exchange.

What Is the Stock Symbol for Bonesupport?

The stock symbol for Bonesupport is "BONEX."

What Is the Bonesupport Market Cap?

As of today, Bonesupport market cap is 17.72B.

What Is Bonesupport's Earnings Per Share (TTM)?

The Bonesupport EPS (TTM) is 1.86.

When Is the Next Bonesupport Earnings Date?

Bonesupport will release its next earnings report on 14 Jul 2025.

From a Technical Analysis Perspective, Is BONEX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Bonesupport Stock Split?

Bonesupport has split 0 times.

How Many Employees Does Bonesupport Have?

Bonesupport has 140 employees.

What is the current trading status of Bonesupport (BONEX)?

As of 21 Jun 2025, Bonesupport (BONEX) is trading at a price of 269.00, with a previous close of 269.80. The stock has fluctuated within a day range of 266.40 to 272.00, while its 52-week range spans from 244.00 to 405.80.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.